Tae Min Kim
机构：Seoul National University, New Generation University College, Seoul National University Hospital · ORCID：0000-0001-6145-4426
发表论文 802 篇 · 总被引 22668 次 · h-index 70
代表论文
- Bosmolisib (BR101801), a novel PI3K-δ/γ and DNA-PK inhibitor for relapsed/refractory patients with peripheral T-cell lymphoma: a phase I study (2026 · Blood Cancer Journal)
- EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferation (2026 · Neoplasia)
- In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations (2026 · Translational Oncology)
- A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib (2026 · Future Oncology)
- DISCOURSE MARKERS IN INTERNET COMMUNICATION: A PRAGMATIC ASPECT (2026 · Zenodo (CERN European Organization for Nuclear Research))
- DISCOURSE MARKERS IN INTERNET COMMUNICATION: A PRAGMATIC ASPECT (2026 · Zenodo (CERN European Organization for Nuclear Research))